Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
This study is currently recruiting participants.
Study NCT00679315   Information provided by Samsung Medical Center
First Received: May 14, 2008   Last Updated: July 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Female Voiding Dysfunction
Interventions listed in this trial
alfuzosin hydrochloride XL 10mg
Placebo
Additional drug interventions recognized in this trial
Alfuzosin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Samsung Medical Center
Handok Pharmaceuticals Co., Ltd.
The Korean Urological Association


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services